Skip to main content

Infectious Disease Assessment

  • Chapter
  • First Online:
Patient Assessment in Clinical Pharmacy
  • 7945 Accesses

Abstract

Unnecessary broad-spectrum antimicrobial exposure to patients can result in preventable adverse effects, drug–drug or drug–disease interactions, costs, and institutionalization. Pharmacist education includes acquiring expertise in the pharmacology and spectrum of the most commonly used antimicrobials as well as the commonly seen infectious syndromes and organisms and their unique resistance patterns. In clinical practice, pharmacists are tasked to maintain competency in the management of different infectious syndromes, acquire knowledge on novel antimicrobials, and minimize the impact of inappropriate use of antimicrobials while ensuring resolution of an infection. A structured approach to assessing patients with infections ensures that antimicrobial use is appropriate: the right drug, dose, and duration for the right indication.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 159.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, et al. Infectious diseases society of American and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. CID. 2007;44:159–77.

    Article  Google Scholar 

  2. Lau JSY, Kiss C, Roberts E, Horne K, Korman TM, Woolley I. Surveillance of life-long antibiotics: a review of antibiotic prescribing practices in an Australian healthcare network. Ann Clin Microbiol Antimicrob. 2017;16:3. https://doi.org/10.1186/s12941-017-0180-6. PubMed PMID: 28100229; PubMed Central PMCID: PMC 5241934.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Eliopoulos GM, Moellering RC. Principles of anti-infective therapy. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 8th ed. Philadelphia: Elsevier Inc; 2015. p. 224–34.

    Google Scholar 

  4. Singer M, Deutschman CS, Seymour SW, Shankar-Hari M, Annane D, Bauer M, et al. The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 2016;315(8):801–10.

    Article  CAS  Google Scholar 

  5. Kumar A, Roberts D, Wood KE, Light B, Parillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34(6):1589–96.

    Article  Google Scholar 

  6. Lagace-Wien P, Rubinstein E. Adverse reactions to beta-lactam antimicrobials. Expert Opin Drug Saf. 2012;11(3):381–99. https://doi.org/10.1517/14740338.2012.643866. PubMed PMID: 22220627.

    Article  CAS  Google Scholar 

  7. Park MA, Li JT. Diagnosis and management of penicillin allergy. Mayo Clin Proc. 2005;80(3):405–10. PubMed PMID: 1575702.

    Article  Google Scholar 

  8. Terico AT, Gallagher JC. Beta-lactam hypersensitivity and cross-reactivity. J of Pharm Pract. 2014;27(6):530–44. https://doi.org/10.1177/0897190014546109. PubMed PMID: 25124380.

    Article  Google Scholar 

  9. Kuruvilla ME, Khan DA. Antibiotic allergy. In: Bennett JE, Dolin R, Blaser MJ, editors. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. 8th ed. Philadelphia: Elsevier Inc; 2015. p. 298–303.

    Google Scholar 

  10. McDanel JS, Perencevich EN, Diekema DJ, Herwaldt LA, Smith TC, Chrischilles EA, et al. Comparative effectiveness of beta-lactams versus vancomycin for treatment of methicillin-susceptible Staphylococcus aureus bloodstream infections among 122 hospitals. CID. 2015;61(3):361–7.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Cecilia Lau .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lau, C. (2019). Infectious Disease Assessment. In: Mahmoud, S. (eds) Patient Assessment in Clinical Pharmacy. Springer, Cham. https://doi.org/10.1007/978-3-030-11775-7_25

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-11775-7_25

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-11774-0

  • Online ISBN: 978-3-030-11775-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics